Dr. Reddy’s Laboratories has recalled 58,656 bottles of its heartburn drug Lansoprazole in the United States due to a microbial contamination.

The U.S. Food and Drug Administration (U.S. FDA) has classified the recall of the drug as ‘Class II’, which indicates a remote chance of severe adverse consequences or death due to the product flaw.

The U.S. FDA has been cracking down heavily on Indian drug makers for non-compliance of manufacturing norms.

More In: Industry | Business